Skip to main
HSIC

Henry Schein (HSIC) Stock Forecast & Price Target

Henry Schein (HSIC) Analyst Ratings

Based on 14 analyst ratings
Buy
Strong Buy 14%
Buy 43%
Hold 36%
Sell 7%
Strong Sell 0%

Bulls say

Henry Schein is a top performer in the dental industry, with a strong market share, growth, and margins, and a promising outlook under new CEO leadership. While there may be concerns about competition and revenue growth, the company's diversified product offerings and dominant position in the resilient dental market make them a promising investment opportunity. However, investors should be wary of potential challenges and risks, such as competition and market volatility, that could impact the company's performance.

Bears say

Henry Schein is a solidly-positioned company in the dental industry with potential for growth due to positive market trends and a diverse product/service offering. However, risks exist in terms of technological disruptions and regulatory changes. Companies in similar markets, like medication management with Omnicell, also face potential challenges in terms of adoption rates and global expansion.

Henry Schein (HSIC) has been analyzed by 14 analysts, with a consensus rating of Buy. 14% of analysts recommend a Strong Buy, 43% recommend Buy, 36% suggest Holding, 7% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of Henry Schein and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About Henry Schein (HSIC) Forecast

Analysts have given Henry Schein (HSIC) a Buy based on their latest research and market trends.

According to 14 analysts, Henry Schein (HSIC) has a Buy consensus rating as of Sep 16, 2026. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $92.50, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $92.50, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

Henry Schein (HSIC)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.